Patient-centric trials such as decentralized clinical trials (DCTs) or hybrid clinical trials can create complex challenges for drug management and distribution.
Interactive Response Technology (IRT) plays an increasingly significant role in delivering an efficient and streamlined experience for patients, sites, and sponsors. Understanding how this technology can be used more effectively to deliver a better experience while minimizing risks to clinical trials will be one key to the successful adoption of decentralized and hybrid clinical trials.
